Replies to post #183093 on Innovation Pharmaceuticals Inc (IPIX)

[sox040713]

Exactly. Shorter trial and approval time mean more revenue. One year saved could equal to $1B extra in sales. That's why I see the 505(b)(2) pathway as a leverage for CTIX. This recent blog talks more about it.

http://www.cellceutix.com/new-blog/2017/5/8/prurisol-for-psoriasisenrollment-update-for-ongoing-phase-2b-study